EMBL-EBI | Chemical Biology | ChEBI
Example searches: iron*, InChI=1S/CH4O/c1-2/h2H,1H3, caffeine | Advanced Search
| Formula | C4H4O4.C19H32N2.C19H32N2.C4H4O4.C4H4O4 |
| Net Charge | 0 |
| Average Mass | 925.174 |
| Monoisotopic Mass | 924.54597 |
| SMILES | O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.O=C(O)/C=C/C(=O)O.[H][C@]12CN(CC3CC3)C[C@]([H])(CN(CC3CC3)C1)C21CCCC1.[H][C@]12CN(CC3CC3)C[C@]([H])(CN(CC3CC3)C1)C21CCCC1 |
| InChI | InChI=1S/2C19H32N2.3C4H4O4/c2*1-2-8-19(7-1)17-11-20(9-15-3-4-15)12-18(19)14-21(13-17)10-16-5-6-16;3*5-3(6)1-2-4(7)8/h2*15-18H,1-14H2;3*1-2H,(H,5,6)(H,7,8)/b;;3*2-1+/t2*17-,18+;;; |
| InChIKey | AZPYPAVFNGFTGB-ORRJWUSCSA-N |
| Roles Classification |
|---|
| Application: | anti-arrhythmia drug A drug used for the treatment or prevention of cardiac arrhythmias. Anti-arrhythmia drugs may affect the polarisation-repolarisation phase of the action potential, its excitability or refractoriness, or impulse conduction or membrane responsiveness within cardiac fibres. |
| ChEBI Ontology |
|---|
| Outgoing Relation(s) |
| tedisamil sesquifumarate (CHEBI:752601) has functional parent pentacarboxylic acid (CHEBI:35743) |
| tedisamil sesquifumarate (CHEBI:752601) has role anti-arrhythmia drug (CHEBI:38070) |
| tedisamil sesquifumarate (CHEBI:752601) is a organooxygen compound (CHEBI:36963) |
| Synonyms | Source |
|---|---|
| KC-8857 SESQUIFUMARATE | ChEMBL |
| Tedisamil sesquifumarate | ChEMBL |